comparemela.com

Latest Breaking News On - Oranim plus pharm ltd - Page 1 : comparemela.com

IM Cannabis : Management s Discussion and Analysis Q2 2023

IM Cannabis Corp: IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

Company to continue its focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets and accelerating path to profitability, while actively

IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.